Suppr超能文献

接触性皮炎由依氟康唑和卢立康唑引起。

Contact Dermatitis Caused by Efinaconazole and Luliconazole.

机构信息

Department of Dermatology, Nippon Medical School.

出版信息

J Nippon Med Sch. 2021 Jun 30;88(3):253-257. doi: 10.1272/jnms.JNMS.2021_88-312. Epub 2020 Aug 31.

Abstract

We report a case of contact dermatitis caused by both efinaconazole, a topical triazole antifungal drug, and luliconazole, a topical imidazole antifungal drug. Positive patch test reactions were observed with efinaconazole and luliconazole. A patch test with lanoconazole also elicited a positive reaction. We hypothesized that structural similarity between luliconazole and lanoconazole led to cross-reaction, and that the dithiolane ring common to both drugs or the structure of the vinyl imidazole with a dithiolane ring could be the antigenic determinant. Since efinaconazole and luliconazole have no common structures, patients could be sensitized to both drugs separately. The antigenic determinant of efinaconazole is unknown. However, the chemical formula of ravuconazole, an oral triazole antifungal drug, is similar to that of efinaconazole. Clinicians should carefully consider potential cross-reactivity between these drugs.

摘要

我们报告了一例由外用三唑类抗真菌药物依氟康唑和外用咪唑类抗真菌药物卢立康唑引起的接触性皮炎。依氟康唑和卢立康唑的斑贴试验均呈阳性反应。用拉莫康唑进行斑贴试验也引起了阳性反应。我们假设卢立康唑和拉莫康唑之间的结构相似导致了交叉反应,而两种药物共有的二硫戊环或带有二硫戊环的乙烯基咪唑结构可能是抗原决定簇。由于依氟康唑和卢立康唑没有共同的结构,患者可能会分别对这两种药物产生过敏反应。依氟康唑的抗原决定簇尚不清楚。然而,口服三唑类抗真菌药物拉夫康唑的化学公式与依氟康唑相似。临床医生应仔细考虑这些药物之间的潜在交叉反应。

相似文献

1
Contact Dermatitis Caused by Efinaconazole and Luliconazole.接触性皮炎由依氟康唑和卢立康唑引起。
J Nippon Med Sch. 2021 Jun 30;88(3):253-257. doi: 10.1272/jnms.JNMS.2021_88-312. Epub 2020 Aug 31.
3
Onychomadesis caused by efinaconazole.由艾氟康唑引起的甲脱失症。
Contact Dermatitis. 2017 Jan;76(1):57-58. doi: 10.1111/cod.12658.
5
Allergic contact dermatitis from luliconazole.来自卢立康唑的变应性接触性皮炎。
Contact Dermatitis. 2007 May;56(5):296-7. doi: 10.1111/j.1600-0536.2006.01023.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验